Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial

Authors:

Abstract
Summary: Aim: To assess the effects of iron removal on cytochrome P450 2E1 activity and oxidative stress in dysmetabolic iron overload syndrome.Methods: Forty‐eight patients were randomized to phlebotomy therapy consisting of removal of 300–500 mL of blood every 14 days until serum ferritin levels dropped under 100 μg/L or to follow‐up without phlebotomy therapy. Cytochrome P450 2E1 activity was measured at baseline and at the end of treatment by using the 6‐hydroxychlorzoxazone/chlorzoxazone blood metabolic ratio, 2 h after the intake of 500 mg of chlorzoxazone.Results: In the treatment group, a mean of 3.9 ± 1.3 L of blood was removed and serum ferritin levels dropped from 715 ± 397 to 74 ± 34 μg/L. Variation of cytochrome P450 2E1 activity was not significantly different between the 2 groups (0.07 ± 0.26 vs. 0.03 ± 0.19, P = 0.36). In the treatment group, low‐density lipoprotein cholesterol and vitamin E were lowered after treatment compared with control group (−0.15 ± 0.51 vs. 0.24 ± 0.58, P = 0.002 and −1.3 ± 4.4 vs. 2.3 ± 5.2, P = 0.03, respectively). Inversely, vitamin C was increased (0.5 ± 3.5 vs. −1.8 ± 3.9, P = 0.03).Conclusions: In dysmetabolic iron overload syndrome, reduction of iron stores does not significantly influence cytochrome P450 2E1 activity but is associated with a significant decrease of low‐density lipoprotein cholesterol, suggesting that venesection therapy may be a suitable option in these patients.

This publication has 23 references indexed in Scilit: